002728 特一药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.14014.83213.37510.8383.924
总资产报酬率 ROA (%)0.10910.0107.7285.8731.942
投入资产回报率 ROIC (%)0.11410.5358.1316.0952.012

边际利润分析
销售毛利率 (%)39.55356.14949.03653.03448.302
营业利润率 (%)0.49527.48022.16918.5419.202
息税前利润/营业总收入 (%)0.17527.90624.55722.56814.974
净利润/营业总收入 (%)0.85723.72320.10016.7406.925

收益指标分析
经营活动净收益/利润总额(%)-456.236101.83996.315105.423123.104
价值变动净收益/利润总额(%)95.4530.1230.1734.28828.544
营业外收支净额/利润总额(%)-41.565-0.095-0.1144.439-9.278

偿债能力分析
流动比率 (X)1.7722.3731.0181.4341.058
速动比率 (X)1.2001.7890.8301.0410.838
资产负债率 (%)24.08019.97744.88038.9370.521
带息债务/全部投入资本 (%)20.19614.62540.37334.94049.507
股东权益/带息债务 (%)387.723573.437144.273182.87699.653
股东权益/负债合计 (%)315.276400.570122.817156.82891.898
利息保障倍数 (X)-1.00561.72510.1797.1282.285

营运能力分析
应收账款周转天数 (天)48.09432.26234.60835.08946.659
存货周转天数 (天)276.740184.643160.762196.319213.640